In particular, TLR4 is seen to be upregulated in HSPCs of MDS patients and correlates with increased apoptosis of BM-mononuclear cells (BM-MNCs) and CD34+ cells. The gene discussed is TLR4; the disease is myelodysplastic syndrome.